Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 12, 2016

Total Value ($000): $382,095 (100.0% shares, 0.0% debt)

Holdings (9)

— ABIOMED INC 36.0%

Value ($000) $137,475 Shares 1,450,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 21.0%

Value ($000) $80,177 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— ENTELLUS MED INC 18.2%

Value ($000) $69,362 Shares 3,813,197 Est. Cost $21.90 Unrealized —

— CORIUM INTL INC 9.4%

Value ($000) $36,104 Shares 9,353,304 Est. Cost $7.77 Unrealized —

AXGN AXOGEN INC 6.8%

Value ($000) $26,056 Shares 4,861,111 Est. Cost $4.01 Unrealized +26.7%

— ENDOLOGIX INC 4.4%

Value ($000) $16,776 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 2.2%

Value ($000) $8,591 Shares 1,170,370 Est. Cost $2.95 Unrealized +68.0%

ACUR ACURA PHARMACEUTICALS INC 1.4%

Value ($000) $5,537 Shares 1,956,397 Est. Cost $3.40 Unrealized -37.5%

— CATALYST BIOSCIENCES INC 0.5%

Value ($000) $2,017 Shares 1,179,352 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	1,450,000	$137,475	36.0%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$80,177	21.0%	$31.50	—	COM	761330109
—	ENTELLUS MED INC	3,813,197	$69,362	18.2%	$21.90	—	COM	29363K105
—	CORIUM INTL INC	9,353,304	$36,104	9.4%	$7.77	—	COM	21887L107
AXGN	AXOGEN INC	4,861,111	$26,056	6.8%	$4.01	+26.7%	COM	05463X106
—	ENDOLOGIX INC	1,257,468	$16,776	4.4%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$8,591	2.2%	$2.95	+68.0%	COM NEW	58468P206
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$5,537	1.4%	$3.40	-37.5%	COM PAR $0.01	00509L802
—	CATALYST BIOSCIENCES INC	1,179,352	$2,017	0.5%	$4.80	—	COM	14888D109